WO2026038174 - CRYSTALLINE FORMS OF RESMETIROM
National phase entry is expected:
Publication Number
WO/2026/038174
Publication Date
19.02.2026
International Application No.
PCT/IB2025/058258
International Filing Date
14.08.2025
Title **
[English]
CRYSTALLINE FORMS OF RESMETIROM
[French]
FORMES CRISTALLINES DE RESMETIROM
Applicants **
APITORIA PHARMA PRIVATE LIMITED
Inventors
NEELA, Praveen Kumar
ALI, Nasir
MUPPALLA, Siva Ramakrishna
KOREPU, Padma
Priority Data
202441061623
14.08.2024
IN
202441080287
22.10.2024
IN
202541001536
07.01.2025
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2209 | |
| EPO | Filing, Examination, Granting | 11611 | |
| Japan | Filing, Examination, Granting | 2169 | |
| South Korea | Filing, Examination, Granting | 2180 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
25,309
Contact Us
Abstract[English]
The present invention relates to novel crystalline forms of Resmetirom and processes for preparation thereof. Specifically, the present application relates to crystalline forms of REE-1, REE-2 and REE-7 of Resmetirom and processes for preparation thereof.[French]
La présente invention concerne de nouvelles formes cristallines de resmetirom et des procédés pour leur préparation. Plus particulièrement, la présente demande concerne des formes cristallines REE-1, REE-2 et REE-7 de resmetirom et des procédés pour leur préparation.